KACTUS, a biotechnology research reagent provider based in Waltham, Massachusetts, announced the commercial availability of ultra-low endotoxin recombinant human kallikrein-1 proteins designed to ...

Research shows that modifying the gut microbiome can enhance cognitive performance and mitigate dementia risk, highlighting ...

This article traces the history of high-throughput screening (HTS), describes key technological milestones, and examines the ...

A study by researchers at the University of California San Diego could make it easier to treat breast cancer by uncovering a ...

Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for ...

Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

BioAtla, Inc. (NASDAQ: BCAB or the "Company"), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic ...

A team from UNIGE has designed a molecular system that distinguishes and neutralizes cancer cells with unprecedented ...

News Mirrored molecules target disordered proteins in Alzheimer’s disease. 2026-03-31T09:28:00. Researchers at Kobe University have developed a novel approach to Alzheimer’s d ...

The Share Consolidation is intended to increase the per share trading price of the Common Stock to enable the Company to regain compliance with the $1.00 minimum bid price requirement for continued ...